Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gabrielli

Showing results (161-170 of 424) with videos related to

Pageof 43
Sort By:
Circulation|November 19, 2003
Recommended guidelines for uniform reporting of data from drowning: the "Utstein style"A H Idris, R A Berg, J Bierens, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 6, 2007
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virusV De Re, L Caggiari, S De Vita, et al.
Journal of Wound Care|June 12, 2016
Recommendations for the management of biofilm: a consensus documentT Bianchi, R D Wolcott, A Peghetti, et al.
Recenti Progressi in Medicina|April 29, 1998
[High prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma at the onset. Preliminary results of an Italian multicenter study]C Catassi, E Fabiani, G V Coppa, et al.
Journal of Internal Medicine|January 29, 2021
Tocilizumab in COVID-19 interstitial pneumoniaG Pomponio, A Ferrarini, M Bonifazi, et al.
Recenti Progressi in Medicina|December 9, 1998
[Assessment of clinical competence of medical school graduates in Italy with standardized patients. The opinion of the examinees]S Sensi, M F Ben-David, M T Guagnano, et al.
Arthritis and Rheumatism|December 8, 2011
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitisS De Vita, L Quartuccio, M Isola, et al.
Annals of the Rheumatic Diseases|July 26, 2011
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centresJ Fransen, D Popa-Diaconu, R Hesselstrand, et al.
Annals of the Rheumatic Diseases|May 15, 2001
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centresA Della Rossa, G Valentini, S Bombardieri, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, M Geroldinger-Simić, A Kreuter, et al.
Pageof 43

Showing results (161-170 of 424) with videos related to

Sort By:
Pageof 43
Circulation|November 19, 2003
Recommended guidelines for uniform reporting of data from drowning: the "Utstein style"A H Idris, R A Berg, J Bierens, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 6, 2007
Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virusV De Re, L Caggiari, S De Vita, et al.
Journal of Wound Care|June 12, 2016
Recommendations for the management of biofilm: a consensus documentT Bianchi, R D Wolcott, A Peghetti, et al.
Recenti Progressi in Medicina|April 29, 1998
[High prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma at the onset. Preliminary results of an Italian multicenter study]C Catassi, E Fabiani, G V Coppa, et al.
Journal of Internal Medicine|January 29, 2021
Tocilizumab in COVID-19 interstitial pneumoniaG Pomponio, A Ferrarini, M Bonifazi, et al.
Recenti Progressi in Medicina|December 9, 1998
[Assessment of clinical competence of medical school graduates in Italy with standardized patients. The opinion of the examinees]S Sensi, M F Ben-David, M T Guagnano, et al.
Arthritis and Rheumatism|December 8, 2011
A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitisS De Vita, L Quartuccio, M Isola, et al.
Annals of the Rheumatic Diseases|July 26, 2011
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centresJ Fransen, D Popa-Diaconu, R Hesselstrand, et al.
Annals of the Rheumatic Diseases|May 15, 2001
European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centresA Della Rossa, G Valentini, S Bombardieri, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 8, 2024
Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, M Geroldinger-Simić, A Kreuter, et al.
Pageof 43